264 related articles for article (PubMed ID: 31053072)
1. Comparing sequence and structure of falcipains and human homologs at prodomain and catalytic active site for malarial peptide based inhibitor design.
Musyoka TM; Njuguna JN; Tastan Bishop Ö
Malar J; 2019 May; 18(1):159. PubMed ID: 31053072
[TBL] [Abstract][Full Text] [Related]
2. Regulatory elements within the prodomain of Falcipain-2, a cysteine protease of the malaria parasite Plasmodium falciparum.
Pandey KC; Barkan DT; Sali A; Rosenthal PJ
PLoS One; 2009 May; 4(5):e5694. PubMed ID: 19479029
[TBL] [Abstract][Full Text] [Related]
3. Independent intramolecular mediators of folding, activity, and inhibition for the Plasmodium falciparum cysteine protease falcipain-2.
Pandey KC; Sijwali PS; Singh A; Na BK; Rosenthal PJ
J Biol Chem; 2004 Jan; 279(5):3484-91. PubMed ID: 14625277
[TBL] [Abstract][Full Text] [Related]
4. South African Abietane Diterpenoids and Their Analogs as Potential Antimalarials: Novel Insights from Hybrid Computational Approaches.
Musyoka T; Bishop ÖT
Molecules; 2019 Nov; 24(22):. PubMed ID: 31703388
[TBL] [Abstract][Full Text] [Related]
5. Allosteric Site Inhibitor Disrupting Auto-Processing of Malarial Cysteine Proteases.
Pant A; Kumar R; Wani NA; Verma S; Sharma R; Pande V; Saxena AK; Dixit R; Rai R; Pandey KC
Sci Rep; 2018 Nov; 8(1):16193. PubMed ID: 30385827
[TBL] [Abstract][Full Text] [Related]
6. Structure Based Docking and Molecular Dynamic Studies of Plasmodial Cysteine Proteases against a South African Natural Compound and its Analogs.
Musyoka TM; Kanzi AM; Lobb KA; Tastan Bishop Ö
Sci Rep; 2016 Mar; 6():23690. PubMed ID: 27030511
[TBL] [Abstract][Full Text] [Related]
7. Characterisation of plasmodial transketolases and identification of potential inhibitors: an in silico study.
Boateng RA; Tastan Bishop Ö; Musyoka TM
Malar J; 2020 Nov; 19(1):442. PubMed ID: 33256744
[TBL] [Abstract][Full Text] [Related]
8. Folding of the Plasmodium falciparum cysteine protease falcipain-2 is mediated by a chaperone-like peptide and not the prodomain.
Sijwali PS; Shenai BR; Rosenthal PJ
J Biol Chem; 2002 Apr; 277(17):14910-5. PubMed ID: 11827964
[TBL] [Abstract][Full Text] [Related]
9. The Plasmodium falciparum cysteine protease falcipain-2 captures its substrate, hemoglobin, via a unique motif.
Pandey KC; Wang SX; Sijwali PS; Lau AL; McKerrow JH; Rosenthal PJ
Proc Natl Acad Sci U S A; 2005 Jun; 102(26):9138-43. PubMed ID: 15964982
[TBL] [Abstract][Full Text] [Related]
10. Analysis of non-peptidic compounds as potential malarial inhibitors against Plasmodial cysteine proteases via integrated virtual screening workflow.
Musyoka TM; Kanzi AM; Lobb KA; Tastan Bishop Ö
J Biomol Struct Dyn; 2016 Oct; 34(10):2084-101. PubMed ID: 26471975
[TBL] [Abstract][Full Text] [Related]
11. Computation-based virtual screening for designing novel antimalarial drugs by targeting falcipain-III: a structure-based drug designing approach.
Kesharwani RK; Singh DV; Misra K
J Vector Borne Dis; 2013; 50(2):93-102. PubMed ID: 23995310
[TBL] [Abstract][Full Text] [Related]
12. Identification and biochemical characterization of vivapains, cysteine proteases of the malaria parasite Plasmodium vivax.
Na BK; Shenai BR; Sijwali PS; Choe Y; Pandey KC; Singh A; Craik CS; Rosenthal PJ
Biochem J; 2004 Mar; 378(Pt 2):529-38. PubMed ID: 14629194
[TBL] [Abstract][Full Text] [Related]
13. Critical role of amino acid 23 in mediating activity and specificity of vinckepain-2, a papain-family cysteine protease of rodent malaria parasites.
Singh A; Shenai BR; Choe Y; Gut J; Sijwali PS; Craik CS; Rosenthal PJ
Biochem J; 2002 Nov; 368(Pt 1):273-81. PubMed ID: 12169096
[TBL] [Abstract][Full Text] [Related]
14. Characterization of amino acid variation at strategic positions in parasite and human proteases for selective inhibition of falcipains in Plasmodium falciparum.
Goh LL; Sim TS
Biochem Biophys Res Commun; 2005 Sep; 335(3):762-70. PubMed ID: 16095562
[TBL] [Abstract][Full Text] [Related]
15. Independent amino acid residues in the S2 pocket of falcipain-3 determine its specificity for P2 residues in substrates.
Kolla VK; Prasad R; Sayyad Z; Atul ; Shah AY; Allanki AD; Navale R; Singhal N; Tanneru N; Sudhakar R; Venkatesan V; Deshmukh MV; Sijwali PS
Mol Biochem Parasitol; 2015 Aug; 202(2):11-22. PubMed ID: 26439304
[TBL] [Abstract][Full Text] [Related]
16. Structural characterization of vivapain-2 and vivapain-3, cysteine proteases from Plasmodium vivax: comparative protein modeling and docking studies.
Desai PV; Avery MA
J Biomol Struct Dyn; 2004 Jun; 21(6):781-90. PubMed ID: 15107000
[TBL] [Abstract][Full Text] [Related]
17. A prodomain peptide of Plasmodium falciparum cysteine protease (falcipain-2) inhibits malaria parasite development.
Korde R; Bhardwaj A; Singh R; Srivastava A; Chauhan VS; Bhatnagar RK; Malhotra P
J Med Chem; 2008 Jun; 51(11):3116-23. PubMed ID: 18461922
[TBL] [Abstract][Full Text] [Related]
18. Structural basis for unique mechanisms of folding and hemoglobin binding by a malarial protease.
Wang SX; Pandey KC; Somoza JR; Sijwali PS; Kortemme T; Brinen LS; Fletterick RJ; Rosenthal PJ; McKerrow JH
Proc Natl Acad Sci U S A; 2006 Aug; 103(31):11503-8. PubMed ID: 16864794
[TBL] [Abstract][Full Text] [Related]
19. The Ionic and hydrophobic interactions are required for the auto activation of cysteine proteases of Plasmodium falciparum.
Sundararaj S; Singh D; Saxena AK; Vashisht K; Sijwali PS; Dixit R; Pandey KC
PLoS One; 2012; 7(10):e47227. PubMed ID: 23077573
[TBL] [Abstract][Full Text] [Related]
20. Expression and characterization of the Plasmodium falciparum haemoglobinase falcipain-3.
Sijwali PS; Shenai BR; Gut J; Singh A; Rosenthal PJ
Biochem J; 2001 Dec; 360(Pt 2):481-9. PubMed ID: 11716777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
